Global Uric Acid Drug Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
- BMR3856532
- 111 Pages
- May 2020
- Healthcare
Prior to COVID-19, the global market for Uric Acid Drug was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Uric Acid Drug is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Uric Acid Drug market.
In terms of production side, this report researches the Uric Acid Drug production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Uric Acid Drug by regions (countries) and by Application.
The global Uric Acid Drug market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Uric Acid Drug market. These figures have been provided in terms of both revenue and volume for the period 2015-2026. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Uric Acid Drug market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Uric Acid Drug industry.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Uric Acid Drug markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For the period 2015-2025, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Uric Acid Drug market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Uric Acid Drug market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Uric Acid Drug market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2015-2020.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Uric Acid Drug market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Uric Acid Drug market by each type segment for the period 2015-2025. It also offers volume sales (consumption) analysis and forecast of the global Uric Acid Drug market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Uric Acid Drug market by each application segment for the same period.
This report includes the following manufacturers:
AstraZeneca plc
Boehringer Ingelheim GmbH
Teijin Pharma Ltd
Regeneron Pharmaceuticals
GlaxoSmithKline plc
Merck & Co. Inc
Novartis AG
Savient Pharmaceuticals
Ironwood Pharmaceuticals
Market Segment by Type
Allopurinol
Febuxostat
Probenecid
Market Segment by Application
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
Research Methodology
To compile the detailed study of the global Uric Acid Drug market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Uric Acid Drug market. QY Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Uric Acid Drug market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1.1 Research Scope
1.2 Top Uric Acid Drug Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Uric Acid Drug Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Allopurinol
1.3.3 Febuxostat
1.3.4 Probenecid
1.4 Market Segment by Application
1.4.1 Global Uric Acid Drug Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Online Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Hospital Pharmacies
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 Study Objectives
1.7 Years Considered
2 Global Market Perspective
2.1 Global Uric Acid Drug Revenue (2015-2026)
2.1.1 Global Uric Acid Drug Revenue (2015-2026)
2.1.2 Global Uric Acid Drug Sales (2015-2026)
2.2 Covid-19 Impact on Global Uric Acid Drug Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Uric Acid Drug Sales by Regions (2015-2020)
2.2.2 Global Uric Acid Drug Revenue by Regions (2015-2020)
2.3 Global Top Uric Acid Drug Regions (Countries) Ranking by Market Size
2.4 Uric Acid Drug Industry Trends
2.4.1 Covid-19 Impact: Uric Acid Drug Market Trends
2.4.2 Covid-19 Impact: Uric Acid Drug Market Drivers
2.4.3 Covid-19 Impact: Uric Acid Drug Market Challenges
2.4.4 Covid-19 Impact: Uric Acid Drug Market Restraints
2.4.5 Primary Interviews with Key Uric Acid Drug Players: Views for Future
3 Covid-19 Impact on Competitive Landscape by Manufacturers
3.1 Global Top Uric Acid Drug Manufacturers by Sales (2015-2020)
3.1.1 Global Uric Acid Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Uric Acid Drug Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Uric Acid Drug Sales in 2019
3.2 Global Top Manufacturers Uric Acid Drug by Revenue
3.2.1 Global Uric Acid Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Uric Acid Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Uric Acid Drug Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uric Acid Drug as of 2019)
3.4 Global Uric Acid Drug Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Uric Acid Drug Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Uric Acid Drug Market
3.7 Key Manufacturers Uric Acid Drug Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Impact on Market Size by Type
4.1 Global Uric Acid Drug Historic Market Review by Type (2015-2020)
4.1.2 Global Uric Acid Drug Sales Market Share by Type (2015-2020)
4.1.3 Global Uric Acid Drug Revenue Market Share by Type (2015-2020)
4.1.4 Uric Acid Drug Price by Type (2015-2020)
4.1 Global Uric Acid Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Uric Acid Drug Sales Forecast by Type (2021-2026)
4.2.3 Global Uric Acid Drug Revenue Forecast by Type (2021-2026)
4.2.4 Uric Acid Drug Price Forecast by Type (2021-2026)
5 Covid-19 Impact on Global Uric Acid Drug Market Size by Application
5.1 Global Uric Acid Drug Historic Market Review by Application (2015-2020)
5.1.2 Global Uric Acid Drug Sales Market Share by Application (2015-2020)
5.1.3 Global Uric Acid Drug Revenue Market Share by Application (2015-2020)
5.1.4 Uric Acid Drug Price by Application (2015-2020)
5.2 Global Uric Acid Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Uric Acid Drug Sales Forecast by Application (2021-2026)
5.2.3 Global Uric Acid Drug Revenue Forecast by Application (2021-2026)
5.2.4 Uric Acid Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Uric Acid Drug Breakdown Data by Company
6.2 North America Uric Acid Drug Breakdown Data by Type
6.3 North America Uric Acid Drug Breakdown Data by Application
6.4 North America Uric Acid Drug Breakdown Data by Countries
6.4.1 North America Uric Acid Drug Sales by Countries
6.4.2 North America Uric Acid Drug Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Uric Acid Drug Breakdown Data by Company
7.2 Europe Uric Acid Drug Breakdown Data by Type
7.3 Europe Uric Acid Drug Breakdown Data by Application
7.4 Europe Uric Acid Drug Breakdown Data by Countries
7.4.1 Europe Uric Acid Drug Sales by Countries
7.4.2 Europe Uric Acid Drug Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Uric Acid Drug Breakdown Data by Company
8.2 Asia Pacific Uric Acid Drug Breakdown Data by Type
8.3 Asia Pacific Uric Acid Drug Breakdown Data by Application
8.4 Asia Pacific Uric Acid Drug Breakdown Data by Regions
8.4.1 Asia Pacific Uric Acid Drug Sales by Regions
8.4.2 Asia Pacific Uric Acid Drug Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Uric Acid Drug Breakdown Data by Company
9.2 Latin America Uric Acid Drug Breakdown Data by Type
9.3 Latin America Uric Acid Drug Breakdown Data by Application
9.4 Latin America Uric Acid Drug Breakdown Data by Countries
9.4.1 Latin America Uric Acid Drug Sales by Countries
9.4.2 Latin America Uric Acid Drug Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Uric Acid Drug Breakdown Data by Type
10.2 Middle East and Africa Uric Acid Drug Breakdown Data by Application
10.3 Middle East and Africa Uric Acid Drug Breakdown Data by Countries
10.3.1 Middle East and Africa Uric Acid Drug Sales by Countries
10.3.2 Middle East and Africa Uric Acid Drug Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 AstraZeneca plc
11.1.1 AstraZeneca plc Corporation Information
11.1.2 AstraZeneca plc Business Overview and Total Revenue (2019 VS 2018)
11.1.3 AstraZeneca plc Uric Acid Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 AstraZeneca plc Uric Acid Drug Products and Services
11.1.5 AstraZeneca plc SWOT Analysis
11.1.6 AstraZeneca plc Recent Developments and Reaction to Covid-19
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Corporation Information
11.2.2 Boehringer Ingelheim GmbH Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Boehringer Ingelheim GmbH Uric Acid Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Boehringer Ingelheim GmbH Uric Acid Drug Products and Services
11.2.5 Boehringer Ingelheim GmbH SWOT Analysis
11.2.6 Boehringer Ingelheim GmbH Recent Developments and Reaction to Covid-19
11.3 Teijin Pharma Ltd
11.3.1 Teijin Pharma Ltd Corporation Information
11.3.2 Teijin Pharma Ltd Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Teijin Pharma Ltd Uric Acid Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Teijin Pharma Ltd Uric Acid Drug Products and Services
11.3.5 Teijin Pharma Ltd SWOT Analysis
11.3.6 Teijin Pharma Ltd Recent Developments and Reaction to Covid-19
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Corporation Information
11.4.2 Regeneron Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Regeneron Pharmaceuticals Uric Acid Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Regeneron Pharmaceuticals Uric Acid Drug Products and Services
11.4.5 Regeneron Pharmaceuticals SWOT Analysis
11.4.6 Regeneron Pharmaceuticals Recent Developments and Reaction to Covid-19
11.5 GlaxoSmithKline plc
11.5.1 GlaxoSmithKline plc Corporation Information
11.5.2 GlaxoSmithKline plc Business Overview and Total Revenue (2019 VS 2018)
11.5.3 GlaxoSmithKline plc Uric Acid Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline plc Uric Acid Drug Products and Services
11.5.5 GlaxoSmithKline plc SWOT Analysis
11.5.6 GlaxoSmithKline plc Recent Developments and Reaction to Covid-19
11.6 Merck & Co. Inc
11.6.1 Merck & Co. Inc Corporation Information
11.6.2 Merck & Co. Inc Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Merck & Co. Inc Uric Acid Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Merck & Co. Inc Uric Acid Drug Products and Services
11.6.5 Merck & Co. Inc SWOT Analysis
11.6.6 Merck & Co. Inc Recent Developments and Reaction to Covid-19
11.7 Novartis AG
11.7.1 Novartis AG Corporation Information
11.7.2 Novartis AG Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Novartis AG Uric Acid Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Novartis AG Uric Acid Drug Products and Services
11.7.5 Novartis AG SWOT Analysis
11.7.6 Novartis AG Recent Developments and Reaction to Covid-19
11.8 Savient Pharmaceuticals
11.8.1 Savient Pharmaceuticals Corporation Information
11.8.2 Savient Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Savient Pharmaceuticals Uric Acid Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Savient Pharmaceuticals Uric Acid Drug Products and Services
11.8.5 Savient Pharmaceuticals SWOT Analysis
11.8.6 Savient Pharmaceuticals Recent Developments and Reaction to Covid-19
11.9 Ironwood Pharmaceuticals
11.9.1 Ironwood Pharmaceuticals Corporation Information
11.9.2 Ironwood Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Ironwood Pharmaceuticals Uric Acid Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Ironwood Pharmaceuticals Uric Acid Drug Products and Services
11.9.5 Ironwood Pharmaceuticals SWOT Analysis
11.9.6 Ironwood Pharmaceuticals Recent Developments and Reaction to Covid-19
12 Covid-19 Impact on Value Chain and Sales Channels Analysis
12.1 Covid-19 Impact on Uric Acid Drug Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Uric Acid Drug Sales Channels
12.2.2 Uric Acid Drug Distributors
12.3 Uric Acid Drug Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Uric Acid Drug Sales Forecast (2021-2026)
13.1.1 Global Uric Acid Drug Sales Forecast by Regions (2021-2026)
13.1.2 Global Uric Acid Drug Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Uric Acid Drug Sales Forecast (2021-2026)
13.2.2 North America Uric Acid Drug Revenue Forecast (2021-2026)
13.2.3 North America Uric Acid Drug Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Uric Acid Drug Sales Forecast (2021-2026)
13.3.2 Europe Uric Acid Drug Revenue Forecast (2021-2026)
13.3.3 Europe Uric Acid Drug Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Uric Acid Drug Sales Forecast (2021-2026)
13.4.2 Asia Pacific Uric Acid Drug Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Uric Acid Drug Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Uric Acid Drug Sales Forecast (2021-2026)
13.5.2 Latin America Uric Acid Drug Revenue Forecast (2021-2026)
13.5.3 Latin America Uric Acid Drug Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Uric Acid Drug Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Uric Acid Drug Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Uric Acid Drug Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Uric Acid Drug Key Market Segments
Table 2. Ranking of Global Top Uric Acid Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Uric Acid Drug Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Allopurinol
Table 5. Major Manufacturers of Febuxostat
Table 6. Major Manufacturers of Probenecid
Table 7. Global Uric Acid Drug Market Share by Application 2019-2025 (K Units)
Table 8. COVID-19 Impact Global Market: (Four Uric Acid Drug Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Uric Acid Drug Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Uric Acid Drug Players to Combat Covid-19 Impact
Table 13. Global Uric Acid Drug Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 14. Global Uric Acid Drug Sales by Regions 2015-2020 (K Units)
Table 15. Global Uric Acid Drug Sales Market Share by Regions 2015-2020
Table 16. Global Uric Acid Drug Revenue by Regions 2015-2020 (Million US$)
Table 17. Global Uric Acid Drug Revenue Market Share by Regions 2015-2020
Table 18. Top Uric Acid Drug Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 19. Market Top Trends
Table 20. Uric Acid Drug Key Drivers: Impact Analysis (2021-2026)
Table 21. Uric Acid Drug Key Challenges
Table 22. Main Points Interviewed from Key Uric Acid Drug Players: Views for Future
Table 23. Global Uric Acid Drug Sales by Manufacturers (2015-2020) (K Units)
Table 24. Global Uric Acid Drug Sales Share by Manufacturers (2015-2020)
Table 25. Uric Acid Drug Revenue by Manufacturers (2015-2020) (Million US$)
Table 26. Uric Acid Drug Revenue Share by Manufacturers (2015-2020)
Table 27. Global Uric Acid Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uric Acid Drug as of 2019)
Table 29. Key Manufacturers Uric Acid Drug Average Selling Price (ASP) (2015-2020) (US$/Unit)
Table 30. Key Manufacturers Uric Acid Drug Plants/Factories Distribution
Table 31. Key Manufacturers Uric Acid Drug Area Served
Table 32. Date of Key Manufacturers Enter into Uric Acid Drug Market
Table 33. Key Manufacturers Uric Acid Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Allopurinol Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 36. Global Febuxostat Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 37. Global Probenecid Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 38. Global Uric Acid Drug Sales (K Units) by Type (2015-2020)
Table 39. Global Uric Acid Drug Sales Share by Type (2015-2020)
Table 40. Global Uric Acid Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Global Uric Acid Drug Price (K Units) by Type (2015-2020)
Table 42. Global Uric Acid Drug Sales (K Units) by Type (2021-2026)
Table 43. Global Uric Acid Drug Sales Share by Type (2021-2026)
Table 44. Global Uric Acid Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Global Uric Acid Drug Revenue Share by Type (2021-2026)
Table 46. Global Uric Acid Drug Price (K Units) by Type (2021-2026)
Table 47. Global Uric Acid Drug Sales (K Units) by Application (2015-2020)
Table 48. Global Uric Acid Drug Sales Share by Application (2015-2020)
Table 49. Global Uric Acid Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Global Uric Acid Drug Price by Application 2015-2020 (US$/Unit)
Table 51. Global Uric Acid Drug Sales by Application (2015-2020) (K Units)
Table 52. Global Uric Acid Drug Sales Share by Application (2015-2020)
Table 53. Global Uric Acid Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. Global Uric Acid Drug Revenue Share by Application (2021-2026)
Table 55. Global Uric Acid Drug Price (K Units) by Application (2021-2026)
Table 56. North America Uric Acid Drug Sales by Company (2015-2020) (K Units)
Table 57. North America Uric Acid Drug Sales Market Share by Company (2015-2020)
Table 58. North America Uric Acid Drug Sales by Type (2015-2020) (K Units)
Table 59. North America Uric Acid Drug Sales Market Share by Type (2015-2020)
Table 60. North America Uric Acid Drug Sales by Application (2015-2020) (K Units)
Table 61. North America Uric Acid Drug Sales Market Share by Application (2015-2020)
Table 62. North America Uric Acid Drug Sales by Countries (2015-2020) (K Units)
Table 63. North America Uric Acid Drug Sales Market Share by Countries (2015-2020)
Table 64. North America Uric Acid Drug Revenue by Countries (2015-2020) (Million US$)
Table 65. North America Uric Acid Drug Revenue Market Share by Countries (2015-2020)
Table 66. Europe Uric Acid Drug Sales by Company (2015-2020) (K Units)
Table 67. Europe Uric Acid Drug Sales Market Share by Company (2015-2020)
Table 68. Europe Uric Acid Drug Sales by Type (2015-2020) (K Units)
Table 69. Europe Uric Acid Drug Sales Market Share by Type (2015-2020)
Table 70. Europe Uric Acid Drug Sales by Application (2015-2020) (K Units)
Table 71. Europe Uric Acid Drug Sales Market Share by Application (2015-2020)
Table 72. Europe Uric Acid Drug Sales by Countries (2015-2020) (K Units)
Table 73. Europe Uric Acid Drug Sales Market Share by Countries (2015-2020)
Table 74. Europe Uric Acid Drug Revenue by Countries (2015-2020) (Million US$)
Table 75. Europe Uric Acid Drug Revenue Market Share by Countries (2015-2020)
Table 76. Asia Pacific Uric Acid Drug Sales by Regions (2015-2020) (K Units)
Table 77. Asia Pacific Uric Acid Drug Sales Market Share by Regions (2015-2020)
Table 78. Asia Pacific Uric Acid Drug Sales by Type (2015-2020) (K Units)
Table 79. Asia Pacific Uric Acid Drug Sales Market Share by Type (2015-2020)
Table 80. Asia Pacific Uric Acid Drug Sales by Application (2015-2020) (K Units)
Table 81. Asia Pacific Uric Acid Drug Sales Market Share by Application (2015-2020)
Table 82. Asia Pacific Uric Acid Drug Sales by Countries (2015-2020) (K Units)
Table 83. Asia Pacific Uric Acid Drug Sales Market Share by Regions (2015-2020)
Table 84. Asia Pacific Uric Acid Drug Revenue by Regions (2015-2020) (Million US$)
Table 85. Asia Pacific Uric Acid Drug Revenue Market Share by Regions (2015-2020)
Table 86. Latin America Uric Acid Drug Sales by Company (2015-2020) (K Units)
Table 87. Latin America Uric Acid Drug Sales Market Share by Company (2015-2020)
Table 88. Latin America Uric Acid Drug Sales by Type (2015-2020) (K Units)
Table 89. Latin America Uric Acid Drug Sales Market Share by Type (2015-2020)
Table 90. Latin America Uric Acid Drug Sales by Application (2015-2020) (K Units)
Table 91. Latin America Uric Acid Drug Sales Market Share by Application (2015-2020)
Table 92. Latin America Uric Acid Drug Sales by Countries (2015-2020) (K Units)
Table 93. Latin America Uric Acid Drug Sales Market Share by Countries (2015-2020)
Table 94. Latin America Uric Acid Drug Revenue by Countries (2015-2020) (Million US$)
Table 95. Latin America Uric Acid Drug Revenue Market Share by Countries (2015-2020)
Table 96. Middle East and Africa Uric Acid Drug Sales by Type (2015-2020) (K Units)
Table 97. Middle East and Africa Uric Acid Drug Sales Market Share by Type (2015-2020)
Table 98. Middle East and Africa Uric Acid Drug Sales by Application (2015-2020) (K Units)
Table 99. Middle East and Africa Uric Acid Drug Sales Market Share by Application (2015-2020)
Table 100. Middle East and Africa Uric Acid Drug Sales by Countries (2015-2020) (K Units)
Table 101. Middle East and Africa Uric Acid Drug Sales Market Share by Countries (2015-2020)
Table 102. Middle East and Africa Uric Acid Drug Revenue by Countries (2015-2020) (Million US$)
Table 103. Middle East and Africa Uric Acid Drug Revenue Market Share by Countries (2015-2020)
Table 104. AstraZeneca plc Company Details
Table 105. AstraZeneca plc Description and Business Overview
Table 106. AstraZeneca plc Uric Acid Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 107. AstraZeneca plc Uric Acid Drug Sales Growth Rate (2015-2020)
Table 108. AstraZeneca plc Uric Acid Drug Sales Market Share in Global Market
Table 109. AstraZeneca plc Recent Development
Table 110. Boehringer Ingelheim GmbH Company Details
Table 111. Boehringer Ingelheim GmbH Description and Business Overview
Table 112. Boehringer Ingelheim GmbH Uric Acid Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 113. Boehringer Ingelheim GmbH Uric Acid Drug Sales Growth Rate (2015-2020)
Table 114. Boehringer Ingelheim GmbH Uric Acid Drug Sales Market Share in Global Market
Table 115. Boehringer Ingelheim GmbH Recent Development
Table 116. Teijin Pharma Ltd Company Details
Table 117. Teijin Pharma Ltd Description and Business Overview
Table 118. Teijin Pharma Ltd Uric Acid Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 119. Teijin Pharma Ltd Uric Acid Drug Sales Growth Rate (2015-2020)
Table 120. Teijin Pharma Ltd Uric Acid Drug Sales Market Share in Global Market
Table 121. Teijin Pharma Ltd Recent Development
Table 122. Regeneron Pharmaceuticals Company Details
Table 123. Regeneron Pharmaceuticals Description and Business Overview
Table 124. Regeneron Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 125. Regeneron Pharmaceuticals Uric Acid Drug Sales Growth Rate (2015-2020)
Table 126. Regeneron Pharmaceuticals Uric Acid Drug Sales Market Share in Global Market
Table 127. Regeneron Pharmaceuticals Recent Development
Table 128. GlaxoSmithKline plc Company Details
Table 129. GlaxoSmithKline plc Description and Business Overview
Table 130. GlaxoSmithKline plc Uric Acid Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 131. GlaxoSmithKline plc Uric Acid Drug Sales Growth Rate (2015-2020)
Table 132. GlaxoSmithKline plc Uric Acid Drug Sales Market Share in Global Market
Table 133. GlaxoSmithKline plc Recent Development
Table 134. Merck & Co. Inc Company Details
Table 135. Merck & Co. Inc Description and Business Overview
Table 136. Merck & Co. Inc Uric Acid Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 137. Merck & Co. Inc Uric Acid Drug Sales Growth Rate (2015-2020)
Table 138. Merck & Co. Inc Uric Acid Drug Sales Market Share in Global Market
Table 139. Merck & Co. Inc Recent Development
Table 140. Novartis AG Company Details
Table 141. Novartis AG Description and Business Overview
Table 142. Novartis AG Uric Acid Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 143. Novartis AG Uric Acid Drug Sales Growth Rate (2015-2020)
Table 144. Novartis AG Uric Acid Drug Sales Market Share in Global Market
Table 145. Novartis AG Recent Development
Table 146. Savient Pharmaceuticals Company Details
Table 147. Savient Pharmaceuticals Description and Business Overview
Table 148. Savient Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 149. Savient Pharmaceuticals Uric Acid Drug Sales Growth Rate (2015-2020)
Table 150. Savient Pharmaceuticals Uric Acid Drug Sales Market Share in Global Market
Table 151. Savient Pharmaceuticals Recent Development
Table 152. Ironwood Pharmaceuticals Company Details
Table 153. Ironwood Pharmaceuticals Description and Business Overview
Table 154. Ironwood Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 155. Ironwood Pharmaceuticals Uric Acid Drug Sales Growth Rate (2015-2020)
Table 156. Ironwood Pharmaceuticals Uric Acid Drug Sales Market Share in Global Market
Table 157. Ironwood Pharmaceuticals Recent Development
Table 158. Uric Acid Drug Distributors List
Table 159. Uric Acid Drug Customers List
Table 160. Global Uric Acid Drug Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 161. Global Uric Acid Drug Sales Forecast by Type 2021-2026 (K Units)
Table 162. Global Uric Acid Drug Sales Forecast by Application 2021-2026 (K Units)
Table 163. Global Uric Acid Drug Sales Forecast by Regions 2021-2026 (K Units)
Table 164. Global Uric Acid Drug Revenue Forecast by Regions 2021-2026 (Million US$)
Table 165. North America Uric Acid Drug Sales Forecast by Countries 2021-2026 (K Units)
Table 166. North America Uric Acid Drug Revenue Forecast by Countries 2021-2026
Table 167. Europe Uric Acid Drug Sales Forecast by Countries 2021-2026 (K Units)
Table 168. Europe Uric Acid Drug Revenue Market Share Forecast by Countries 2021-2026
Table 169. Asia Pacific Uric Acid Drug Sales Forecast by Regions 2021-2026 (K Units)
Table 170. Asia Pacific Uric Acid Drug Revenue Forecast by Regions 2021-2026 (Million US$)
Table 171. Latin America Uric Acid Drug Sales Forecast by Countries 2021-2026 (K Units)
Table 172. Latin America Uric Acid Drug Revenue Forecast by Countries 2021-2026 (Million US$)
Table 173. Middle East and Africa Uric Acid Drug Sales Forecast by Regions 2021-2026 (K Units)
Table 174. Middle East and Africa Uric Acid Drug Revenue Forecast by Regions 2021-2026 (Million US$)
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Uric Acid Drug Product Picture
Figure 2. Global Uric Acid Drug Sales Market Shar by Type 2015-2026
Figure 3. Allopurinol Figures
Figure 4. Febuxostat Figures
Figure 5. Probenecid Figures
Figure 6. Global Uric Acid Drug Sales Market Share by Application in 2019 & 2026
Figure 7. Online Pharmacies Use Case
Figure 8. Retail Pharmacies Use Case
Figure 9. Hospital Pharmacies Use Case
Figure 10. Uric Acid Drug Report Years Considered
Figure 11. Global Uric Acid Drug Market Size 2015-2026 (Million US$)
Figure 12. Global Uric Acid Drug Sales 2015-2020 (K Units)
Figure 13. Global Uric Acid Drug Market Size Market Share by Regions 2015-2020
Figure 14. Global Uric Acid Drug Sales Market Share by Regions in 2019
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Uric Acid Drug Sales Share by Manufacturers in 2019
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Uric Acid Drug Sales in 2019
Figure 18. Uric Acid Drug Value Share by Manufacturers in 2019
Figure 19. Uric Acid Drug Revenue Share by Manufacturers In 2019
Figure 20. Uric Acid Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Uric Acid Drug Revenue Share by Type (2015-2020)
Figure 22. Global Uric Acid Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 23. Global Uric Acid Drug Market Share by Price Range (2015-2020)
Figure 24. Global Uric Acid Drug Revenue Share by Application (2015-2020)
Figure 25. Global Uric Acid Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 26. North America Uric Acid Drug Revenue Growth Rate 2015-2020 (Million US$)
Figure 27. U.S. Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 28. Canada Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 29. Europe Uric Acid Drug Revenue Growth Rate 2015-2020 (Million US$)
Figure 30. Germany Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 33. Italy Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 34. Russia Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 35. Asia Pacific Uric Acid Drug Revenue Growth Rate 2015-2020 (Million US$)
Figure 36. China Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 37. Japan Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 38. South Korea Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 39. India Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 40. Australia Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 41. Taiwan Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 42. Indonesia Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 43. Thailand Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 44. Malaysia Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 45. Philippines Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 46. Vietnam Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 47. Latin America Uric Acid Drug Revenue Growth Rate 2015-2020 (Million US$)
Figure 48. Mexico Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. Brazil Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 50. Argentina Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 51. Middle East and Africa Uric Acid Drug Revenue Growth Rate 2015-2020 (Million US$)
Figure 52. Turkey Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 53. Saudi Arabia Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.A.E Uric Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 55. AstraZeneca plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Teijin Pharma Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Merck & Co. Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Savient Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Ironwood Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Uric Acid Drug Value Chain
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. North America Uric Acid Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 68. North America Uric Acid Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 69. Europe Uric Acid Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 70. Europe Uric Acid Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 71. Asia Pacific Uric Acid Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 72. Asia Pacific Uric Acid Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 73. Latin America Uric Acid Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 74. Latin America Uric Acid Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 75. Middle East and Africa Uric Acid Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 76. Middle East and Africa Uric Acid Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
